Abolfazl Zarjou Selected Research

Abolfazl Zarjou Research Topics

Disease

9	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 06/2011
9	Inflammation (Inflammations) 12/2021 - 12/2012
5	Chronic Renal Insufficiency 01/2021 - 10/2011
3	Atherosclerosis 01/2020 - 03/2009
3	Anemia 01/2020 - 08/2012
3	Vascular Calcification 06/2019 - 02/2016
2	Reperfusion Injury 01/2021 - 06/2013
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 03/2009
2	Aortic Valve Disease 01/2020 - 01/2019
2	Sepsis (Septicemia) 01/2019 - 06/2011
2	Kidney Diseases (Kidney Disease) 01/2019 - 05/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2016 - 10/2011
2	Fibrosis (Cirrhosis) 07/2015 - 10/2011
2	Rhabdomyolysis 10/2013 - 08/2012
2	Iron Overload 08/2012 - 01/2010
1	Hyperkalemia 10/2022
1	Albuminuria 01/2022
1	Ischemia 01/2022
1	Bone Resorption 01/2020
1	Hemorrhage 01/2020
1	Endotoxemia 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Infections 01/2019
1	Malaria 01/2019
1	Hyperplasia 10/2016
1	Myocardial Infarction 10/2016
1	Vascular Diseases (Vascular Disease) 10/2016
1	Atrial Fibrillation 02/2016
1	Premature Cardiac Complexes (Extrasystoles) 12/2014
1	Hypotension (Low Blood Pressure) 06/2013
1	Vasculitis (Vasculitides) 12/2012
1	Splenomegaly 08/2012
1	Leukocytosis (Pleocytosis) 08/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2012
1	Neoplasms (Cancer) 10/2011
1	Ureteral Obstruction 10/2011
1	Pathologic Processes 10/2011
1	Critical Illness (Critically Ill) 06/2011
1	Metabolic Bone Diseases (Osteopenia) 01/2010
1	Osteoporosis 01/2010

Drug/Important Bio-Agent (IBA)

5	ApoferritinsIBA 06/2019 - 10/2013
5	Heme Oxygenase-1IBA 04/2017 - 05/2012
5	EnzymesIBA 10/2016 - 10/2011
4	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 08/2012
4	Ferritins (Ferritin)IBA 06/2019 - 07/2015
4	IronIBA 06/2019 - 01/2010
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2011
3	Heme (Haem)IBA 01/2019 - 03/2009
3	CytokinesIBA 01/2019 - 05/2012
3	AntioxidantsIBA 10/2016 - 05/2012
2	Erythropoietin FDA Link 01/2020 - 01/2019
2	LigandsIBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2013
1	Ringer's LactateIBA 10/2022
1	PotassiumIBA 10/2022
1	Saline SolutionIBA 10/2022
1	HepcidinsIBA 01/2022
1	CollagenIBA 01/2022
1	CreatinineIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Adenine FDA LinkGeneric 01/2021
1	Calcitonin Receptors (Calcitonin Receptor)IBA 01/2020
1	CalciumIBA 01/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	HematinicsIBA 01/2020
1	Ceruloplasmin (Ferroxidase)IBA 01/2019
1	Prolyl-Hydroxylase InhibitorsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	ZincIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Waste Products (Waste Product)IBA 10/2016
1	BilirubinIBA 10/2016
1	Biliverdine (Biliverdin)IBA 10/2016
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 10/2016
1	OxygenasesIBA 10/2016
1	ChemokinesIBA 07/2015
1	member 2 solute carrier family 11- (proton-coupled divalent metal ion transporters)IBA 10/2013
1	metal transporting protein 1 (ferroportin)IBA 10/2013
1	C-Reactive ProteinIBA 06/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2012
1	Transcription Factors (Transcription Factor)IBA 08/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2012
1	LyasesIBA 10/2011
1	MicroRNAs (MicroRNA)IBA 10/2011
1	CystathionineIBA 10/2011
1	Immunomodulating AgentsIBA 06/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2009
1	oxidized low density lipoproteinIBA 03/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2011
3	Renal Dialysis (Hemodialysis) 02/2016 - 10/2011
1	Erythrocyte Transfusion 10/2022
1	Nephrectomy 01/2022
1	Ligation 01/2019
1	Punctures 01/2019
1	Hemodiafiltration 02/2016
1	Kidney Transplantation 06/2013
1	Length of Stay 06/2011